Monday, March 3rd 2025, 5:50 am
The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over. After nearly three years of high demand and supply chain issues, semaglutide injections are now readily available.
A: Local pharmacies that have been producing compounded versions of these drugs will need to stop. Under new FDA rules, state-licensed pharmacies must stop by April 22, and larger facilities must comply by May 22.
A: Experts warn that compounded versions of weight-loss drugs pose safety risks, such as dosing errors. Kristie Edelen from the Oklahoma Poison Center explains that these versions are often sold online or through clinics without a prescription, leading to potential overdosing and severe side effects like nausea, cramping, and dehydration.
A: Oklahoma Attorney General Gentner Drummond, along with 37 other state attorneys general, is urging the FDA to take stronger action against counterfeit weight-loss drugs. These illegal drugs, often sold online, may contain harmful contaminants or unknown substances, posing serious risks to consumers.
A: Patients are encouraged to double-check their doses and consult a doctor or pharmacist if they have any concerns. They can also contact the Oklahoma Poison Center for guidance.
A: Edelen reports that 78% of calls they receive are related to unintentional therapeutic errors, such as accidentally injecting the wrong amount of the drug or using the wrong syringe.
A: The Oklahoma Poison Center offers 24/7 support for anyone with concerns about medication safety. Patients can reach out for assistance if they suspect issues with their medications.
August 6th, 2025
August 6th, 2025